HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshiki Uchihara Selected Research

14-3-3 Proteins (14-3-3 Protein)

1/201814-3-3 protein sigma isoform co-localizes with phosphorylated α-synuclein in Lewy bodies and Lewy neurites in patients with Lewy body disease.
10/2012Structure-oriented review of 14-3-3 protein isoforms in geriatric neuroscience.
6/201014-3-3 proteins and spinocerebellar ataxia type 1: from molecular interaction to human neuropathology.
9/2007Intranuclear localization and isoform-dependent translocation of 14-3-3 proteins in human brain with infarction.
3/2007Intranuclear immunolocalization of 14-3-3 protein isoforms in brains with spinocerebellar ataxia type 1.
10/200414-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshiki Uchihara Research Topics

Disease

18Parkinson Disease (Parkinson's Disease)
12/2018 - 09/2002
15Alzheimer Disease (Alzheimer's Disease)
12/2021 - 09/2003
9Multiple System Atrophy
10/2017 - 05/2003
8Dementia (Dementias)
01/2021 - 06/2005
6Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
10/2020 - 11/2003
6Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
09/2020 - 03/2012
6Neurodegenerative Diseases (Neurodegenerative Disease)
11/2014 - 11/2003
6Parkinsonian Disorders (Parkinsonism)
01/2014 - 10/2005
5Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2022 - 03/2007
5Corticobasal Degeneration
01/2021 - 11/2003
5Cerebral Infarction
09/2020 - 04/2003
5Lewy Body Disease (Lewy Body Dementia)
01/2018 - 06/2005
4Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
09/2020 - 04/2013
4Infarction (Infarctions)
09/2007 - 04/2003
3Tauopathies
10/2012 - 02/2005
2Necrosis
12/2021 - 08/2012
2Frontotemporal Dementia (Semantic Dementia)
02/2020 - 11/2003
2Neoplasms (Cancer)
01/2020 - 01/2018
2Multiple Sclerosis
08/2019 - 02/2005
2Congenital Abnormalities (Deformity)
01/2019 - 11/2002
2Huntington Disease (Huntington's Disease)
11/2014 - 10/2012
2Ophthalmoplegia (External Ophthalmoplegia)
01/2014 - 01/2012
2Atrophy
01/2012 - 07/2010
2Neuroblastoma
01/2010 - 04/2003
2Brain Edema (Cerebral Edema)
09/2005 - 08/2003
2Down Syndrome (Down's Syndrome)
08/2005 - 03/2005
1Thrombocytopenia (Thrombopenia)
12/2021
1Amyloidosis
10/2021
1Ataxia (Dyssynergia)
10/2021
1Gliosis
01/2021
1Cardiac Arrhythmias (Arrythmia)
01/2020
1Dyspnea (Shortness of Breath)
01/2020
1Edema (Dropsy)
01/2020
1Heart Failure
01/2020
1Muscular Diseases (Myopathy)
01/2020
1Pericardial Effusion
01/2020
1Muscle Weakness
01/2020
1Acquired Immunodeficiency Syndrome (AIDS)
08/2019
1Headache (Headaches)
11/2018
1Leukocytosis (Pleocytosis)
11/2018
1Meningitis
11/2018
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
02/2018
1Brain Infarction
02/2018
1Intracranial Vasospasm
02/2018
1Cerebral Hemorrhage
02/2018
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
02/2018
1X-Linked Bulbo-Spinal Atrophy
11/2014
1Apraxias (Dyspraxia)
01/2014
1Essential Tremor (Essential Tremors)
12/2013
1Anosmia
12/2013
1Pure Autonomic Failure
12/2013
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
10/2012
1Synucleinopathies
10/2012

Drug/Important Bio-Agent (IBA)

103-Iodobenzylguanidine (Iobenguane)IBA
08/2018 - 11/2004
9AntibodiesIBA
09/2007 - 09/2002
7polyglutamineIBA
01/2022 - 11/2002
7Protein Isoforms (Isoforms)IBA
09/2020 - 10/2004
6alpha-SynucleinIBA
01/2021 - 09/2005
6UbiquitinIBA
09/2020 - 08/2005
6SynucleinsIBA
12/2018 - 02/2007
614-3-3 Proteins (14-3-3 Protein)IBA
01/2018 - 10/2004
5EpitopesIBA
02/2020 - 05/2003
5Levodopa (L Dopa)FDA LinkGeneric
01/2014 - 10/2005
4Proteins (Proteins, Gene)FDA Link
02/2020 - 05/2002
3Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
02/2007 - 06/2005
2Ataxin-2IBA
01/2022 - 11/2014
2DNA-Binding Proteins (DNA Binding Protein)IBA
01/2022 - 06/2015
2plexinIBA
12/2021 - 01/2021
2Formaldehyde (Formol)FDA Link
01/2019 - 02/2005
2Indicators and Reagents (Reagents)IBA
11/2018 - 01/2018
2Biomarkers (Surrogate Marker)IBA
09/2015 - 01/2007
2Tissue Plasminogen Activator (Alteplase)FDA Link
08/2012 - 11/2006
2thiazin redIBA
01/2012 - 08/2005
2Fluorescent Dyes (Fluorescent Probes)IBA
01/2012 - 08/2005
2Amino AcidsFDA Link
06/2011 - 04/2011
2Ataxin-1IBA
06/2010 - 03/2007
2Aquaporin 4IBA
09/2005 - 08/2003
2SilverIBA
08/2005 - 03/2005
2tau Proteins (tau Protein)IBA
08/2005 - 02/2005
2Detergents (Detergent)IBA
02/2005 - 05/2003
2Apolipoproteins E (ApoE)IBA
11/2003 - 04/2003
2ApolipoproteinsIBA
11/2003 - 04/2003
1Fatty Acid ElongasesIBA
10/2021
1Prion ProteinsIBA
01/2021
1AsparagineIBA
10/2020
1Aspartic Acid (Aspartate)FDA Link
10/2020
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2020
1Signal Recognition ParticleIBA
01/2020
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2020
1MethylprednisoloneFDA LinkGeneric
01/2020
1Pharmaceutical PreparationsIBA
08/2019
1HMGB1 Protein (HMG1)IBA
02/2018
1ProgranulinsIBA
09/2017
1Amyloid beta-PeptidesIBA
11/2016
1LeptinIBA
08/2015

Therapy/Procedure

4Sympathectomy (Sympathectomies)
11/2008 - 01/2005
2Therapeutics
08/2019 - 08/2012
1Intravenous Injections
12/2021
1Renal Dialysis (Hemodialysis)
10/2021
1Denervation
12/2013